The influence of assay variability on pharmacokinetic parameter estimation

Area of Science:

• Pharmacokinetics
• Pharmacometric modeling
• Assay validation

Background:

• Assay variability is a critical factor in pharmacokinetic (PK) analysis.
• Standard PK modeling methods may be susceptible to bias introduced by assay errors.
• The impact of varying assay error magnitudes on PK parameter estimation requires thorough investigation.

Purpose of the Study:

• To investigate the impact of assay variability on pharmacokinetic modeling.
• To compare the performance of different estimation methods under simulated assay errors.
• To evaluate the reliability of routinely used PK parameter estimation techniques.

Main Methods:

• Simulated 450 datasets from three individuals with first-order absorption and one-compartment model.
• Introduced random assay errors of 10%, 20%, and 30%.
• Compared sequential estimation, nonlinear regression with various weighting schemes, and NONMEM analysis.

Main Results:

• Assay error led to apparent multicompartmental or complex absorption characteristics.
• Maximum concentration and area under the curve were consistently overestimated with increased assay error.
• Standard methods underestimated Ke and overestimated Ka and volume of distribution, with biases increasing with error magnitude.
• NONMEM acceptably estimated all parameters and variabilities, unlike other methods.

Conclusions:

• Routinely applied pharmacokinetic estimation methods often yield biased and imprecise results.
• Assay variability significantly impacts the accuracy of pharmacokinetic parameter estimation.
• NONMEM demonstrated superior performance in handling assay variability compared to standard methods.